Literature DB >> 8712883

Factors associated with the development of vasculitis in rheumatoid arthritis: results of a case-control study.

A E Voskuyl1, A H Zwinderman, M L Westedt, J P Vandenbroucke, F C Breedveld, J M Hazes.   

Abstract

OBJECTIVE: To investigate those characteristics of patients with rheumatoid arthritis (RA) that are associated with the development of rheumatoid vasculitis (RV).
METHODS: Demographic and clinical data of 69 patients who had been diagnosed as having RV were compared with those of 138 contemporaneous control patients with RA who were not suspected to have vasculitis. Vasculitis was confirmed histologically in 96% of the subjects with RV.
RESULTS: Variables associated with the development of RV were: 1) male gender, presence of increased serum concentrations of rheumatoid factor, joint erosions, subcutaneous nodules, number of disease modifying antirheumatic drugs previously prescribed, treatment (ever) with D-penicillamine or azathioprine; 2) presence of nail fold lesions and any other extrarticular feature one year before the time of diagnosis of RV; 3) treatment with corticosteroids at the time of diagnosis of RV.
CONCLUSIONS: The development of RV is associated with male gender, extra-articular features, and a severe course of RA as indicated by the presence of joint destruction and need for intensive treatment with antirheumatic drugs. The strongest association was found with the presence of increased concentrations of rheumatoid factor.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8712883      PMCID: PMC1010127          DOI: 10.1136/ard.55.3.190

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  13 in total

1.  THE NATURAL HISTORY OF VASCULAR LESIONS IN RHEUMATOID ARTHRITIS.

Authors:  E G BYWATERS; J T SCOTT
Journal:  J Chronic Dis       Date:  1963-08

2.  IgM rheumatoid factor and low molecular weight IgM. An association with vasculitis.

Authors:  A N Theofilopoulos; G Burtonboy; J J LoSpalluto; M Ziff
Journal:  Arthritis Rheum       Date:  1974 May-Jun

3.  Smoking and rheumatoid vasculitis.

Authors:  G R Struthers; D L Scott; J P Delamere; H Sheppeard; M Kitt
Journal:  Rheumatol Int       Date:  1981       Impact factor: 2.631

4.  Systemic rheumatoid vasculitis: a clinical and laboratory study of 50 cases.

Authors:  D G Scott; P A Bacon; C R Tribe
Journal:  Medicine (Baltimore)       Date:  1981-07       Impact factor: 1.889

5.  Clinical background of rheumatoid vascular disease.

Authors:  M Wilkinson; W N Torrance
Journal:  Ann Rheum Dis       Date:  1967-11       Impact factor: 19.103

6.  Rheumatoid arthritis--the clinical significance of histo- and immunopathological abnormalities in normal skin.

Authors:  M L Westedt; C J Meijer; B J Vermeer; A Cats; E de Vries
Journal:  J Rheumatol       Date:  1984-08       Impact factor: 4.666

7.  Rheumatoid vasculitis: survival and associated risk factors.

Authors:  R S Vollertsen; D L Conn; D J Ballard; D M Ilstrup; R E Kazmar; J C Silverfield
Journal:  Medicine (Baltimore)       Date:  1986-11       Impact factor: 1.889

8.  Prognostic factors for radiographic damage and physical disability in early rheumatoid arthritis. A prospective follow-up study of 147 patients.

Authors:  D M van der Heijde; P L van Riel; M A van Leeuwen; M A van 't Hof; M H van Rijswijk; L B van de Putte
Journal:  Br J Rheumatol       Date:  1992-08

9.  Detection of immune complexes and their relationship to rheumatoid factor in a variety of autoimmune disorders.

Authors:  R M Pope; S Yoshinoya; S J McDuffy
Journal:  Clin Exp Immunol       Date:  1981-11       Impact factor: 4.330

10.  Illustrated histopathologic classification criteria for selected vasculitis syndromes. American College of Rheumatology Subcommittee on Classification of Vasculitis.

Authors:  J T Lie
Journal:  Arthritis Rheum       Date:  1990-08
View more
  33 in total

1.  An assessment of ocular elasticity using real time ultrasound and ocular response analyzer in active or remission rheumatoid arthritis.

Authors:  Mehmet Erol Can; Özlem Unal; Meltem Ece Kars; Sukran Erten; Gamze Dereli Can; Necati Duru; Nurullah Cagil
Journal:  Int Ophthalmol       Date:  2018-12-03       Impact factor: 2.031

Review 2.  Rheumatoid Vasculitis: A Diminishing Yet Devastating Menace.

Authors:  Shweta Kishore; Lisa Maher; Vikas Majithia
Journal:  Curr Rheumatol Rep       Date:  2017-07       Impact factor: 4.592

3.  Peripheral neuropathy in two patients with rheumatoid arthritis receiving infliximab treatment.

Authors:  Maria G Tektonidou; John Serelis; Fotini N Skopouli
Journal:  Clin Rheumatol       Date:  2006-07-06       Impact factor: 2.980

Review 4.  [Systemic manifestations of rheumatoid arthritis].

Authors:  M Uffmann
Journal:  Radiologe       Date:  2006-05       Impact factor: 0.635

5.  Rapid progression of scleroderma possibly associated with penicillamine therapy.

Authors:  Y S Haviv; R Safadi
Journal:  Clin Drug Investig       Date:  1998       Impact factor: 2.859

6.  Rheumatoid arthritis: Rheumatoid vasculitis--down but not out.

Authors:  Richard A Watts
Journal:  Nat Rev Rheumatol       Date:  2014-03-04       Impact factor: 20.543

Review 7.  Gastrointestinal and Hepatic Disease in Rheumatoid Arthritis.

Authors:  Ethan Craig; Laura C Cappelli
Journal:  Rheum Dis Clin North Am       Date:  2018-02       Impact factor: 2.670

8.  Vasculitis associated with rheumatoid arthritis: a case-control study.

Authors:  Ashima Makol; Cynthia S Crowson; David A Wetter; Olayemi Sokumbi; Eric L Matteson; Kenneth J Warrington
Journal:  Rheumatology (Oxford)       Date:  2014-01-17       Impact factor: 7.580

9.  Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years.

Authors:  C Turesson; W M O'Fallon; C S Crowson; S E Gabriel; E L Matteson
Journal:  Ann Rheum Dis       Date:  2003-08       Impact factor: 19.103

10.  Decline in rheumatoid vasculitis prevalence among US veterans: a retrospective cross-sectional study.

Authors:  Christie Bartels; Carolyn Bell; Ann Rosenthal; Kazuhiko Shinki; Alan Bridges
Journal:  Arthritis Rheum       Date:  2009-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.